Literature DB >> 25926624

Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader-Willi syndrome.

Igor Pravdivyi1, Klaus Ballanyi2, William F Colmers3, Rachel Wevrick4.   

Abstract

Prader-Willi syndrome (PWS) is a multigene disorder associated with neonatal failure to thrive, developmental delay and endocrine abnormalities suggestive of hypothalamic dysfunction. Children with PWS typically develop overt hyperphagia and obesity ∼8 years of age, later than children with other genetic forms of obesity. This suggests a postnatal developmental or degenerative component to PWS-associated obesity. De novo inactivating mutations in one PWS candidate gene, MAGEL2, have been identified in children with features of PWS. Adult mice lacking Magel2 are insensitive to the anorexic effect of leptin treatment, and their hypothalamic pro-opiomelanocortin (POMC) neurons fail to depolarize in response to leptin. However, it is unclear whether this leptin insensitivity is congenital, or whether normal leptin sensitivity in neonatal Magel2-null mice is lost postnatally. We used in vitro cytosolic calcium imaging to follow the postnatal development of leptin responses in POMC neurons in these mice. Leptin caused an activation of POMC neurons in wild-type acute hypothalamic slice preparations at all ages, reflecting their normal leptin-invoked depolarization. Normal leptin responses were found in Magel2-null mice up to 4 weeks of age, but the proportion of leptin-responsive POMC neurons was reduced in 6-week-old Magel2-null mice. The number of α-melanocyte-stimulating hormone immunoreactive fibers in the paraventricular hypothalamic nucleus was also reduced in mutant mice at 6 weeks of age. A similar progressive loss of leptin sensitivity caused by loss of MAGEL2 in children with PWS could explain the delayed onset of increased appetite and weight gain in this complex disorder.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25926624     DOI: 10.1093/hmg/ddv159

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

Review 1.  Energy Metabolism Profile in Individuals with Prader-Willi Syndrome and Implications for Clinical Management: A Systematic Review.

Authors:  Maha Alsaif; Sarah A Elliot; Michelle L MacKenzie; Carla M Prado; Catherine J Field; Andrea M Haqq
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

2.  Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.

Authors:  Miki Igarashi; Vidya Narayanaswami; Virginia Kimonis; Pietro M Galassetti; Fariba Oveisi; Kwang-Mook Jung; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2016-12-19       Impact factor: 7.658

Review 3.  Role of genomic imprinting in mammalian development.

Authors:  Thushara Thamban; Viplove Agarwaal; Sanjeev Khosla
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

4.  Forebrain neurogenesis: From embryo to adult.

Authors:  Daniel Dennis; David Picketts; Ruth S Slack; Carol Schuurmans
Journal:  Trends Dev Biol       Date:  2016-01-01

Review 5.  Prader-Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach.

Authors:  Silvia Savastano; Giovanna Muscogiuri; Luigi Barrea; Claudia Vetrani; Danilo Fintini; Giulia de Alteriis; Filippo Maria Panfili; Sarah Bocchini; Ludovica Verde; Annamaria Colao
Journal:  Curr Obes Rep       Date:  2022-09-05

6.  Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.

Authors:  Jocelyn M Bischof; Lex H T Van Der Ploeg; William F Colmers; Rachel Wevrick
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

7.  Loss of Magel2 impairs the development of hypothalamic Anorexigenic circuits.

Authors:  Julien Maillard; Soyoung Park; Sophie Croizier; Charlotte Vanacker; Joshua H Cook; Vincent Prevot; Maithe Tauber; Sebastien G Bouret
Journal:  Hum Mol Genet       Date:  2016-06-10       Impact factor: 6.150

8.  The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.

Authors:  Tishani Methsala Wijesuriya; Leentje De Ceuninck; Delphine Masschaele; Matthea R Sanderson; Karin Vanessa Carias; Jan Tavernier; Rachel Wevrick
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

Review 9.  New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain.

Authors:  Julio D Perez; Nimrod D Rubinstein; Catherine Dulac
Journal:  Annu Rev Neurosci       Date:  2016-04-25       Impact factor: 12.449

10.  From leptin to lasers: the past and present of mouse models of obesity.

Authors:  Joshua R Barton; Adam E Snook; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2021-01-29       Impact factor: 7.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.